Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Jan;143(Suppl 1):S37-S43.
doi: 10.1542/peds.2018-1099H.

Returning a Genomic Result for an Adult-Onset Condition to the Parents of a Newborn: Insights From the BabySeq Project

Ingrid A Holm  1   2 , Amy McGuire  3 , Stacey Pereira  3 , Heidi Rehm  4   5   6   7 , Robert C Green  6   8   9 , Alan H Beggs  10   2 ; BabySeq Project Team
Collaborators, Affiliations
Case Reports

Returning a Genomic Result for an Adult-Onset Condition to the Parents of a Newborn: Insights From the BabySeq Project

Ingrid A Holm et al. Pediatrics. 2019 Jan.

Abstract

The return of information from genomic sequencing in children, especially in early life, brings up complex issues around parental autonomy, the child's future autonomy, the best interest standard, and the best interests of the family. These issues are particularly important in considering the return of genomic results for adult-onset-only conditions in children. The BabySeq Project is a randomized trial used to explore the medical, behavioral, and economic impacts of integrating genomic sequencing into the care of newborns who are healthy or sick. We discuss a case in which a variant in a gene for an actionable, adult-onset-only condition was detected, highlighting the ethical issues surrounding the return of such finding in a newborn to the newborn's parents.

PubMed Disclaimer

Conflict of interest statement

POTENTIAL CONFLICT OF INTEREST: Dr Green is co-founder, advisor, and equity holder in Genome Medical, Inc; the other authors have indicated they have no conflicts of interest to disclose.

References

    1. Green RC, Rehm HL, Kohane IS. Clinical genome sequencing In: Ginsburg GS, Willard HF, eds. Genomic and Personalized Medicine. Vol 1 2nd ed. San Diego, CA: Elsevier Inc; 2013:102–122
    1. Biesecker LG, Green RC. Diagnostic clinical genome and exome sequencing. N Engl J Med. 2014;370(25):2418–2425 - PubMed
    1. Baylor College of Medicine. Medical genetics laboratories: whole genome laboratory (WGL). 2012. Available at: www.bcm.edu/geneticlabs/index.cfm?PMID=21319. Accessed June 13, 2012
    1. Dewey FE, Grove ME, Pan C, et al. Clinical interpretation and implications of whole-genome sequencing. JAMA. 2014;311 (10):1035–1045 - PMC - PubMed
    1. Krier J, Barfield R, Green RC, Kraft P. Reclassification of genetic-based risk predictions as GWAS data accumulate. Genome Med. 2016;8(1):20. - PMC - PubMed

Publication types